Potent In Vitro Synergism of Fluconazole and Berberine Chloride against Clinical Isolates of Candida albicans Resistant to Fluconazole-Reference-Cited by-同舟云学术

Potent In Vitro Synergism of Fluconazole and Berberine Chloride against Clinical Isolates of Candida albicans Resistant to Fluconazole

Published:2006-03 Issue:3 Volume:50 Page:1096-1099
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Quan Hua¹,Cao Ying-Ying²,Xu Zheng¹,Zhao Jing-Xia³,Gao Ping-Hui¹,Qin Xiao-Feng⁴,Jiang Yuan-Ying¹

Affiliation:

1. Department of Pharmacology, School of Pharmacy, Second Military Medical University

2. Department of Biochemical Pharmacy, School of Pharmacy, Second Military Medical University

3. Department of Organic Chemistry, School of Pharmacy, Second Military Medical University

4. Department of Dermatology, Changhai Hospital of Second Military Medical University, Shanghai 200433, People's Republic of China

Abstract

ABSTRACT In vitro interaction of fluconazole and berberine chloride was investigated against 40 fluconazole-resistant clinical isolates of Candida albicans . Synergism in fungistatic activity was found with the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed the synergistic interaction, but no antagonistic action was observed.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.50.3.1096-1099.2006

Reference29 articles.

1. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

2. Boken, D. J., S. Swindells, and M. G. Rinaldi. 1993. Fluconazole-resistant Candida albicans. Clin. Infect. Dis.17:1018-1021.

3. Brammer, K. W., P. R. Farrow, and J. K. Faulkner. 1990. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis.12(Suppl. 3):S318-S326.

4. D'Auria, F. D., M. Tecca, R. Strippoli, and N. Simonetti. 2001. In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains. Lett. Appl. Microbiol.32:220-223.

5. Edwards, J. E., Jr., G. P. Bodey, R. A. Bowden, T. Buchner, B. E. de Pauw, S. G. Filler, M. A. Ghannoum, M. Glauser, R. Herbrecht, C. A. Kauffman, S. Kohno, P. Martino, F. Meunier, T. Mori, M. A. Pfaller, J. H. Rex, T. R. Rogers, R. H. Rubin, J. Solomkin, C. Viscoli, T. J. Walsh, and M. White. 1997. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin. Infect. Dis.25:43-59.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Novel Potent Tetrazole Antifungal Candidate with High Selectivity and Broad Spectrum;Journal of Medicinal Chemistry;2024-04-10

2. Activity of thonningianin A against Candida albicans in vitro and in vivo;Applied Microbiology and Biotechnology;2024-01-11

3. Biochanin A Inhibits the Growth and Biofilm of Candida Species;Pharmaceuticals;2024-01-09

4. Discovery of Novel 8-Hydroxyquinoline Derivatives with Potent In Vitro and In Vivo Antifungal Activity;Journal of Medicinal Chemistry;2023-11-17

5. Synergistic Effect of Plant Compounds in Combination with Conventional Antimicrobials against Biofilm of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp.;Pharmaceuticals;2023-10-30